首页> 外文期刊>Saudi Journal of Biological Sciences >Construction of miRNA-mRNA network for the identification of key biological markers and their associated pathways in IgA nephropathy by employing the integrated bioinformatics analysis
【24h】

Construction of miRNA-mRNA network for the identification of key biological markers and their associated pathways in IgA nephropathy by employing the integrated bioinformatics analysis

机译:用综合生物信息学分析施用MiRNA-mRNA网络的鉴定鉴定关键生物标记及其在IgA肾病中的相关途径

获取原文
           

摘要

Background About half-century ago, Immunoglobulin A nephropathy (IgAN) was discovered as a complicated disease with frequent clinical symptoms. Until now, exact mechanism underlying the pathogenesis of IgAN is poorly known. Therefore, current study was aimed to understand the molecular mechanism of IgAN by identifying the key miRNAs and their targeted hub genes. The key miRNAs might contribute to the diagnosis and therapy of IgAN, and could turn out to be a new star in the field of IgAN. Methods The microarray datasets were downloaded from Gene Expresssion Omnibus (GEO) database and analyzed using R package (LIMMA) in order to obtain differential expressed genes (DEGs). Then, the hub genes were identified using cytoHubba plugin of cytoscpae tool and other bioinformatics approaches including protein-protein interaction (PPI) network analysis, module analysis, and miRNA-hub gene network construction was also performed. Results A total of 348 DEGs were identified, of which 107 were upregulated genes and 241 were downregulated genes. Subsequently, the 12 overlapped genes were predicted from cytoHubba, and considered as hub genes. Moreover, a network among miRNA-hub genes was created to explore the correlation between the hub genes and their targeted miRNAs. Network construction ultimately lead to the identification of nine gene named FN1, EGR1, FOS, JUN, SERPINE1, MMP2, ATF3, MYC, and IL1B and one novel key miRNA namely, has-miR-144-3p as biomarker for diagnosis and therapy of IgAN. Conclusion This study updates the information and yield a new perspective in context of understanding the pathogenesis and development of IgAN. In future, key miRNAs might be capable of improving the personalized detection and therapies for IgAN. In vivo and in vitro investigation of miRNAs and pathway interaction is essential to delineate the specific roles of the novel miRNAs, which may help to further reveal the mechanisms underlying IgAN.
机译:背景大约半个世纪以前,免疫球蛋白是一种肾病(Igan)被发现为常见临床症状的复杂疾病。到目前为止,IGAN发病机制的确切机制是令人着名的。因此,目前的研究旨在通过鉴定关键miRNA及其靶向中心基因来了解IgAn的分子机制。关键的miRNA可能有助于IGAN的诊断和治疗,并可能成为IGAN领域的新星。方法从基因Expression omnibus(Geo)数据库下载微阵列数据集,并使用R包(利马)分析以获得差异表达的基因(DEGS)。然后,使用Cytoscpae工具的CytoHubba插件和包括蛋白质 - 蛋白质相互作用(PPI)网络分析,模块分析和miRNA-Hub基因网络构建的其他生物信息学方法鉴定了轮毂基因。结果鉴定了总共348℃,其中107个是上调基因,241是下调的基因。随后,从细胞凋亡中预测12个重叠的基因,并被视为枢纽基因。此外,创建了MiRNA-Hub基因中的网络以探讨枢纽基因与其靶向miRNA之间的相关性。网络施工最终导致鉴定为FN1,EGR1,FOS,Jun,Serpine1,MMP2,ATF3,MyC和IL1B以及一部分新的密钥MiRNA的九种基因,即,MIR-144-3P作为生物标志物,用于诊断和治疗Igan。结论本研究更新信息,并在理解IGAN发病机制和发展的背景下产生新的视角。将来,关键的miRNA可能能够改善Igan的个性化检测和疗法。体内和体外调查miRNA和途径相互作用对于描绘新型miRNA的特定作用至关重要,这可能有助于进一步揭示Igan下面的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号